← Leaderboards
Kenneth R Chien
University Of California San Diego
$8,287,418
Attributed
$11,693,663
Total exposure
14
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$27,279,885 · 16
By mechanism
P01$10,604,085 · 4
P50$6,721,127 · 3
U01$3,876,985 · 1
R01$3,154,255 · 2
T32$1,784,949 · 1
RC1$997,013 · 1
Top collaborators
- Douglas A Melton3 shared
- Kevin Kit Parker3 shared
- Sean M Wu3 shared
- William T Pu2 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Howard A Rockman$36,912,571
- Andrew D. McCulloch$21,376,228
- Wolfgang H Dillmann$17,750,136
- Gianluigi Condorelli$2,255,321
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseCardiac MyocytesBiological Signal TransductionHeart FailureGenetically Modified AnimalsGene TargetingVentricular HypertrophyDevelopmental GeneticsGene MutationMutationMolecular PathologyPhenotypeCardiacDisease /Disorder ModelMyocardialHeartLinkMortality Vital StatisticsTissue /Cell CultureGeneticBaseCellsBiomechanicsCardiovascular System
Grant awards (44)
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,288,595
U01 · FY2011 · HL · contact PI
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,272,877
U01 · FY2010 · HL · contact PI
Characterization of Cardiac Progenitors Derived from 22q11-deleted Patients$497,013
RC1 · FY2010 · HL
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases$1,315,513
U01 · FY2009 · HL · contact PI
Characterization of Cardiac Progenitors Derived from 22q11-deleted Patients$500,000
RC1 · FY2009 · HL
Multipotent heart cell progenitor lineages in cardiac development and disease$42,016
R03 · FY2009 · HL · contact PI
Cytoskeletal-Associated Proteins and Cardiomyopathy$381,091
R01 · FY2008 · HL · contact PI
Cytoskeletal-Associated Proteins and Cardiomyopathy$365,165
R01 · FY2007 · HL · contact PI
Cytoskeletal-Associated Proteins and Cardiomyopathy$363,503
R01 · FY2006 · HL · contact PI
T-TUBLES IN MLPKO$10,172
P41 · FY2006 · RR · contact PI
Cytoskeletal-Associated Proteins and Cardiomyopathy$368,168
R01 · FY2005 · HL
T-TUBLES IN MLPKO$8,643
P41 · FY2005 · RR
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY$2,112,637
P01 · FY2004 · HL
MOLECULAR PHYSIOLOGY OF HEART FAILURE$1,116,089
P50 · FY2004 · HL
Translational Cardiovascular Science and Medicine$428,828
T32 · FY2004 · HL
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY$2,055,203
P01 · FY2003 · HL
MOLECULAR PHYSIOLOGY OF HEART FAILURE$1,211,395
P50 · FY2003 · HL
VITAMIN A SIGNALING AND CARDIAC MORPHOGENIC DEFECTS$436,366
R01 · FY2003 · HL
Translational Cardiovascular Science and Medicine$406,080
T32 · FY2003 · HL
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY$1,995,340
P01 · FY2002 · HL
MOLECULAR PHYSIOLOGY OF HEART FAILURE$1,180,235
P50 · FY2002 · HL
VITAMIN A SIGNALING AND CARDIAC MORPHOGENIC DEFECTS$426,217
R01 · FY2002 · HL
TRAINING IN THE MOLECULAR BASIS OF HEART DISEASE$305,479
T32 · FY2002 · HL
11Q DELETIONS AND HYPOPLASTIC LEFT HEART SYNDROME$186,685
P50 · FY2002 · HL
Nodal pathways for cardiac failure in genetically engineered mice$139,182
P50 · FY2002 · HL
Biomedical stress pathways and cardiomyopathy$0
P01 · FY2002 · HL
SIGNALING PATHWAYS FOR CARDIAC GROWTH AND HYPERTROPHY$1,860,282
P01 · FY2001 · HL
MOLECULAR PHYSIOLOGY OF HEART FAILURE$1,131,631
P50 · FY2001 · HL
VITAMIN A SIGNALING AND CARDIAC MORPHOGENIC DEFECTS$415,802
R01 · FY2001 · HL
TRAINING IN THE MOLECULAR BASIS OF HEART DISEASE$362,486
T32 · FY2001 · HL
11Q DELETIONS AND HYPOPLASTIC LEFT HEART SYNDROME$186,685
P50 · FY2001 · HL
Nodal pathways for cardiac failure in genetically engineered mice$139,182
P50 · FY2001 · HL
CORE--TRANSGENIC ANIMAL FACILITY$106,600
P01 · FY2001 · HL
GP130/RETINOID SIGNALS IN HYPERTROPHY AND CARDIOMYOPATHY$106,600
P01 · FY2001 · HL
NEUREGULIN SIGNALING PATHWAY IN CARDIAC DEVELOPMENT$40,320
R03 · FY2001 · TW
SIGNALING PATHWAYS FOR CARDIAC GROWTH AND HYPERTROPHY$1,809,951
P01 · FY2000 · HL
MOLECULAR PHYSIOLOGY OF HEART FAILURE$1,113,459
P50 · FY2000 · HL
VITAMIN A SIGNALING AND CARDIAC MORPHOGENIC DEFECTS$397,943
R01 · FY2000 · HL
TRAINING IN THE MOLECULAR BASIS OF HEART DISEASE$282,076
T32 · FY2000 · HL
GP130/RETINOID SIGNALS IN HYPERTROPHY AND CARDIOMYOPATHY$278,736
P01 · FY2000 · HL
CORE--TRANSGENIC ANIMAL FACILITY$278,736
P01 · FY2000 · HL
11Q DELETIONS AND HYPOPLASTIC LEFT HEART SYNDROME$177,402
P50 · FY2000 · HL
Nodal pathways for cardiac failure in genetically engineered mice$139,182
P50 · FY2000 · HL
NEUREGULIN SIGNALING PATHWAY IN CARDIAC DEVELOPMENT$40,320
R03 · FY2000 · TW